Perpetua Medical AB (publ) (STO:PERP.B)
3.490
-0.150 (-4.12%)
Jul 24, 2026, 1:03 PM CET
Perpetua Medical AB Revenue
Perpetua Medical AB had revenue of 6.24M SEK in the quarter ending March 31, 2026, with 60.93% growth. This brings the company's revenue in the last twelve months to 28.87M, up 179.58% year-over-year. In the year 2025, Perpetua Medical AB had annual revenue of 26.51M with 87.30% growth.
Revenue (ttm)
28.87M
Revenue Growth
+179.58%
P/S Ratio
1.83
Revenue / Employee
1.48M
Employees
11
Market Cap
29.86M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.51M | 12.36M | 87.30% |
| Dec 31, 2024 | 14.15M | 4.17M | 41.75% |
| Dec 31, 2023 | 9.98M | -433.28K | -4.16% |
| Dec 31, 2022 | 10.42M | 1.42M | 15.80% |
| Dec 31, 2021 | 9.00M | 6.23M | 225.16% |
| Dec 31, 2020 | 2.77M | 548.16K | 24.71% |
| Dec 31, 2019 | 2.22M | 1.18M | 114.34% |
| Dec 31, 2018 | 1.04M | -246.00K | -19.20% |
| Dec 31, 2017 | 1.28M | 1.11M | 653.53% |
| Dec 31, 2016 | 170.00K | -72.00K | -29.75% |
| Dec 31, 2015 | 242.00K | -774.00K | -76.18% |
| Dec 31, 2014 | 1.02M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Boule Diagnostics AB | 461.29M |
| Arcoma AB | 127.06M |
| ScandiDos AB | 58.09M |
| Nosa Plugs AB | 27.87M |
| Iconovo AB | 13.83M |
| Luxbright AB | 13.75M |
| Clinical Laserthermia Systems AB | 12.56M |
| Neola Medical AB | 9.02M |
Perpetua Medical AB News
- 2 months ago - Perpetua Medical AB Quarterly report: Q1 2026 - Filings
- 5 months ago - Perpetua Medical AB Quarterly report: Q4 2025 - Filings
- 5 months ago - Perpetua Medical AB Annual report: Q4 2025 - Filings
- 9 months ago - Perpetua Medical AB Quarterly report: Q3 2025 - Filings
- 1 year ago - Perpetua Medical AB Quarterly report: Q2 2025 - Filings